To include your compound in the COVID-19 Resource Center, submit it here.

Diagnostics plays Guardant, Exosome close private rounds

Two companies in the minimally invasive, fluid-based diagnostics sector announced private funding rounds on Thursday.

Guardant Health Inc. (Redwood City, Calif.) said it

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE